Mirae Asset Global Etfs Holdings Ltd. Arcellx, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Arcellx, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 27,363 shares of ACLX stock, worth $1.66 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,363
Previous 25,774
6.17%
Holding current value
$1.66 Million
Previous $2.15 Million
3.21%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding ACLX
# of Institutions
223Shares Held
44.7MCall Options Held
434KPut Options Held
433K-
Paradigm Biocapital Advisors LP New York, NY4.37MShares$265 Million12.7% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$227 Million20.37% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$213 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY3.48MShares$211 Million8.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.33MShares$202 Million0.0% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $2.66B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...